
    
      Trial Features:

        -  Medical device (Non-drug option)

        -  Most patients can remain on current treatment regimen throughout the study

      Components of the Study:

        -  Study length is 24 weeks, which includes a screening visit, ten treatment visits over
           nine weeks and 4 follow-up appointments

        -  Physical exams, laboratory tests and disease assessments conducted at no charge to the
           patient

        -  2:1 Randomization (treatment:sham)

        -  Open-Label extension offered to eligible patients
    
  